Phase II, Multicenter, Open-label Study to Assess the Efficacy and Safety of Enzalutumide with Trastuzumab in Subjects with Her2+ AR+ Metastatic or Locally Advanced Breast Cancer

Investigator: Hope Rugo, MD
Sponsor: Astellas Pharma, Inc.

Location(s): United States


The purpose of this study is to evaluate the efficacy of enzalutamide with trastuzumab in subjects with HER2+ AR+ and ER-/PgR- metastatic or locally advanced breast cancer.